Cayman

Showing 16201–16350 of 45550 results

  • Cyclooxygenase (COX, also called Prostaglandin H Synthase or PGHS) enzymes contain both cyclooxygenase and peroxidase activities. COX catalyzes the first step in the biosynthesis of prostaglandins (PGs), thromboxanes, and prostacyclins; the conversion of arachidonic acid to PGH2. It is now well established that there are two distinct isoforms of COX. Cyclooxygenase-1 (COX-1) is constitutively expressed in variety of cell types and is involved in normal cellular homeostasis. A variety of mitogenic stimuli such as phorbol esters, lipopolysaccharides, and cytokines lead to the induced expression of a second isoform of COX, cyclooxygenase-2 (COX-2). COX-2 is responsible for the biosynthesis of PGs under acute inflammatory conditions.{4} This inducible COX-2 is believed to be the target enzyme for the anti-inflammatory activity of nonsteroidal anti-inflammatory drugs. The COX (ovine/human) Inhibitor Screening Assay directly measures PGF2α produced by SnCl2 reduction of COX-derived PGH2. The prostanoid product is quantified via enzyme immunosorbent assay (ELISA) using a broadly specific antibody that binds to all the major prostaglandin compounds. Thus, the Cayman COX assay is more accurate and reliable than an assay based on peroxidase inhibition. The Cayman COX Inhibitor Screening Assay includes both ovine COX-1 and human recombinant COX-2 enzymes in order to screen isozyme-specific inhibitors. This assay is an excellent tool which can be used for general inhibitor screening, or to eliminate false positive leads generated by less specific methods.  

     

    Brand:
    Cayman
    SKU:560131 - 96 wells

    Available on backorder

  • The COX Activity Assay utilizes the peroxidase component of cyclooxygenases. The peroxidase activity is assayed colorimetrically by monitoring the appearance of oxidized N,N,N’,N’-tetramethyl-p-phenylenediamine (TMPD) at 590 nm.{8581} The assay can be used to measure COX activity (COX-1 and COX-2) in cell lysates, tissue homogenates, and purified enzyme preparations. The assay includes COX-1 and COX-2 specific inhibitors in order to distinguish between the two isozymes.  

     

    Brand:
    Cayman
    SKU:760151 - 96 wells

    Available on backorder

  • The COX Colorimetric Inhibitor Screening Assay measures the peroxidase component of cyclooxygenases. The peroxidase activity is assayed colorimetrically by monitoring the appearance of oxidized N,N,N’,N’-tetramethyl-p-phenylenediamine (TMPD) at 590 nm.{8581} Inhibition of COX activity, measured by TMPD oxidation, by a variety of selective and nonselective inhibitors, shows changed potencies similar to those observed with other in vitro methods. The COX Colorimetric Inhibitor Screening assay includes both ovine COX-1 and human recombinant COX-2 enzymes in order to screen isozyme-specific inhibitors. The Cayman COX Colorimetric Assay is a time saving tool for screening vast numbers of inhibitors.  

     

    Brand:
    Cayman
    SKU:701050 - 2 x 96 wells

    Available on backorder

  • Cyclooxygenase (COX, also called Prostaglandin H Synthase or PGHS) is a bifunctional enzyme exhibiting both COX and peroxidase activities. The COX component converts arachidonic acid to a hydroperoxy endoperoxide (PGG2), and the peroxidase component reduces the endoperoxide to the corresponding alcohol (PGH2), the precursor of PGs, thromboxanes, and prostacyclins.{500,501} It is now well established that there are two distinct isoforms of COX, namely COX-1 and COX-2. Cayman’s COX Fluorescent Activity Assay provides a convenient fluorescence-based method for detecting COX-1 or COX-2 activity in both crude (cell lysates/tissue homogenates) and purified enzyme preparations. The assay utilizes the peroxidase component of COXs. In this assay, the reaction between PGG2 and ADHP (10-acetyl-3,7-dihydroxyphenoxazine) produces the highly fluorescent compound resorufin that can be analyzed using an excitation wavelength of 530-540 nm and an emission wavelength of 585-595 nm. The kit includes isozyme-specific inhibitors for distinguishing COX-2 activity from COX-1 activity.  

     

    Brand:
    Cayman
    SKU:700200 - 2 x 96 wells

    Available on backorder

  • Cyclooxygenase (COX, also called Prostaglandin H Synthase or PGHS) is a bifunctional enzyme exhibiting both COX and peroxidase activities. The COX component converts arachidonic acid to a hydroperoxy endoperoxide (PGG2), and the peroxidase component reduces the endoperoxide to the corresponding alcohol (PGH2), the precursor of PGs, thromboxanes, and prostacyclins.{500,501} It is now well established that there are two distinct isoforms of COX, COX-1 and COX-2. Cayman’s COX Fluorescent Inhibitor Screening Assay provides a convenient fluorescence-based method for screening ovine COX-1 and human recombinant COX-2 for isozyme-specific inhibitors. The assay utilizes the peroxidase component of COXs. In this assay, the reaction between PGG2 and ADHP (10-acetyl-3,7-dihydroxyphenoxazine) produces the highly fluorescent compound resorufin. Resorufin fluorescence can be analyzed with an excitation wavelength of 530-540 nm and an emission wavelength of 585-595 nm.  

     

    Brand:
    Cayman
    SKU:700100 - 2 x 96 wells

    Available on backorder

  • Brand:
    Cayman
    SKU:460103 - 1 ea

    Available on backorder

  • Brand:
    Cayman
    SKU:460102 - 1 ea

    Available on backorder

  • Brand:
    Cayman
    SKU:460106 - 1 ea

    Available on backorder

  • Brand:
    Cayman
    SKU:460105 - 1 ea

    Available on backorder

  • Brand:
    Cayman
    SKU:460104 - 1 ea

    Available on backorder

  • Brand:
    Cayman
    SKU:460107 - 1 ea

    Available on backorder

  • Immunogen: Purified sheep seminal vesicular COX-1 • Host: Rabbit • Species Reactivity: (+) Murine COX-1, sheep seminal vesicular COX-1, sheep placental COX-2 • Applications: WB  

     

    Brand:
    Cayman
    SKU:160103- 500 µl
  • Cyclooxygenase catalyzes the first step in the biosynthesis of prostaglandins, thromboxanes, and prostacyclins: the conversion of arachidonic acid to prostaglandin H2 COX-1 is constitutively expressed in almost all animal tissues and is involved in the homeostatic role of eicosanoids.{14,767} Recent discoveries of the induction of cyclooxygenase biosynthesis by a variety of stimuli such as phorbol esters, lipopolysaccharides, and cytokines led to the hypothesis that the inducible form of cyclooxygenase, COX-2, is responsible for the biosynthesis of prostaglandins under acute inflammatory conditions.{4} COX-1 and -2 are 70 and 72 kDa proteins, respectively. Both cyclooxygenases have been cloned from a variety of species including human, mouse, rat, and sheep.{13,4051} COX-1 isoform at the amino acid level, whereas the homology between COX-1 and COX-2 is only about 60%.  

     

    Brand:
    Cayman
    SKU:160103 - 500 µl

    Available on backorder

  • Immunogen: Purified sheep seminal vesicular COX-1 • Host: Rabbit • Species Reactivity: (+) Murine COX-1, sheep seminal vesicular COX-1, sheep placental COX-2 • Applications: WB  

     

    Brand:
    Cayman
    SKU:160103- 500 µl

    Available on backorder

  • Cyclooxygenase (COX, also called Prostaglandin H Synthase or PGHS) is a bifunctional enzyme that converts arachidonic acid to a hydroperoxy endoperoxide (PGG2) and reduces the endoperoxide to the corresponding alcohol (PGH2), the precursor of prostaglandins, thromboxanes, and prostacyclins. COX-1 is constitutively expressed in a variety of cell types and is involved in normal cellular homeostasis. The COX-1 (human) Inhibitor Screening Assay directly measures PGF2α by SnCl2 reduction of COX-derived PGH2 produced in the COX reaction. The prostanoid product is quantified via enzyme immunoassay using a broadly specific antiserum that binds to all the major prostaglandin compounds. This assay includes human recombinant COX-1 allowing the user to screen specific inhibitors. This assay is an excellent tool that can be used for general inhibitor screening, or to eliminate false positive leads generated by less specific methods.  

     

    Brand:
    Cayman
    SKU:701070 - 96 wells

    Available on backorder

  • Immunogen: Peptide from the internal region of mouse COX-1 • Host: Rabbit • Species Reactivity: (+) Mouse and ovine; (-) Human; other species not tested • Cross Reactivity: (-) COX-2 (all species) • Application: WB  

     

    Brand:
    Cayman
    SKU:160109- 1 ea
  • COX-1 is responsible for the production of prostaglandins essential for the normal function of many organs including the stomach and kidney.{3463} COX-1 is generally described as being constitutively expressed, although COX-1 expression is regulated developmentally and in response to a variety of other stimuli.{6608,13,1508,12} Mouse COX-1 has a molecular weight of 70,000 and is expressed in nearly all tissues of the body.{3463,300}  

     

    Brand:
    Cayman
    SKU:160109 - 1 ea

    Available on backorder

  • Immunogen: Peptide from the internal region of mouse COX-1 • Host: Rabbit • Species Reactivity: (+) Mouse and ovine; (-) Human; other species not tested • Cross Reactivity: (-) COX-2 (all species) • Application: WB  

     

    Brand:
    Cayman
    SKU:160109- 1 ea

    Available on backorder

  • COX-1 and COX-2 catalyze the production of the prostaglandin (PG) and thromboxane precursor PGH2. COX-2 is primarily responsible for the biosynthesis of PGs under acute inflammatory conditions. The COX-1 (ovine) Inhibitor Screening Assay measures PGF2α that is produced by SnCl2 reduction of COX-1-derived PGH2. PGF2α is quantified via enzyme immunoassay (EIA) using a broadly specific antiserum that binds to all the major PG compounds. This assay includes ovine COX-1 and is an excellent tool which can be used for general inhibitor screening, or to eliminate false positive leads generated by less specific methods.  

     

    Brand:
    Cayman
    SKU:701090 - 96 wells

    Available on backorder

  • Immunogen: purified ovine COX-1 • Host: mouse, clone CX111 • Isotype: IgG2b • Cross Reactivity: (+) human, bovine, mouse, ovine, and rat COX-1, ovine COX-2 (50%), and human COX-2 (~5%); (−) mouse COX-2 • Application(s): IHC and WB  

     

    Brand:
    Cayman
    SKU:160110- 1 ea
  • COX-1 is responsible for the production of prostaglandins essential for the normal function of many organs including stomach and kidney.{3463} Although COX-1 is generally described as constitutively expressed, this is actually an oversimplification. COX-1 expression is regulated developmentally and in response to a variety of other stimuli.{6608,13,1508,12} COX-1 has a molecular weight of 70 kDa and is expressed in nearly all tissues of the body.{3463,13,300,919}  

     

    Brand:
    Cayman
    SKU:160110 - 1 ea

    Available on backorder

  • Immunogen: purified ovine COX-1 • Host: mouse, clone CX111 • Isotype: IgG2b • Cross Reactivity: (+) human, bovine, mouse, ovine, and rat COX-1, ovine COX-2 (50%), and human COX-2 (~5%); (−) mouse COX-2 • Application(s): IHC and WB  

     

    Brand:
    Cayman
    SKU:160110- 1 ea

    Available on backorder

  • Immunogen: Purified ovine COX-1 • Clone designation: CX111 • Host: Mouse • Cross-Reactivity: (+) Ovine COX-2 (50%) • Species Reactivity: (+) Human, bovine, mouse, ovine, and rat • Application: FC  

     

    Brand:
    Cayman
    SKU:160111- 250 µg
  • This product is derived by labeling the COX-1 monoclonal antibody (Item No. 160110) with fluorescein. COX-1 catalyzes the first step in the biosynthesis of prostaglandins, thromboxanes, and prostacyclins: the conversion of arachidonic acid to prostaglandin H2. COX-1 is constitutively expressed in almost all animal tissues and is involved in the homeostatic role of eicosanoids.{14,767} COX-1 is a 70 kDa protein which has been cloned from a variety of species including human, mouse, rat, and sheep.{13,300,5695,919} COX-1 from these species are approximately 90% identical at the amino acid level, whereas the homology between COX-1 and COX-2 is only about 60%.  

     

    Brand:
    Cayman
    SKU:160111 - 250 µg

    Available on backorder

  • Immunogen: Purified ovine COX-1 • Clone designation: CX111 • Host: Mouse • Cross-Reactivity: (+) Ovine COX-2 (50%) • Species Reactivity: (+) Human, bovine, mouse, ovine, and rat • Application: FC  

     

    Brand:
    Cayman
    SKU:160111- 250 µg

    Available on backorder

  • Immunogen: Purified ovine COX-1 • Host: Mouse, clone CX111 • Cross Reactivity: (+) Ovine COX-2 (50%); (−) Mouse COX-2 • Species Reactivity: (+) Human, bovine, mouse, ovine, and rat • Application(s): FC and IF • Isotype: IgG2b • This product is derived by labeling the COX-1 monoclonal antibody (Item No. 160110) with phycoerythrin.  

     

    Brand:
    Cayman
    SKU:160120- 1 ea
  • This product is derived by labeling the COX-1 monoclonal antibody (Item No. 160110) with phycoerythrin. COX-1 is responsible for the production of prostaglandins essential for the normal function of many organs including stomach and kidney.{3463} Although COX-1 is generally described as constitutively expressed, this is actually an oversimplification. COX-1 expression is regulated developmentally and in response to a variety of other stimuli.{6608,13,1508,12} COX-1 has a molecular weight of 70,000 and is expressed in nearly all tissues of the body.{3463,13,300,919}  

     

    Brand:
    Cayman
    SKU:160120 - 1 ea

    Available on backorder

  • Immunogen: Purified ovine COX-1 • Host: Mouse, clone CX111 • Cross Reactivity: (+) Ovine COX-2 (50%); (−) Mouse COX-2 • Species Reactivity: (+) Human, bovine, mouse, ovine, and rat • Application(s): FC and IF • Isotype: IgG2b • This product is derived by labeling the COX-1 monoclonal antibody (Item No. 160110) with phycoerythrin.  

     

    Brand:
    Cayman
    SKU:160120- 1 ea

    Available on backorder

  • COX-1 and COX-2 catalyze the production of the prostaglandin (PG) and thromboxane precursor PGH2. COX-2 is primarily responsible for the biosynthesis of PGs under acute inflammatory conditions. The COX-2 (human recombinant) Inhibitor Screening Assay measures PGF2α that is produced by SnCl2 reduction of COX-2-derived PGH2. PGF2α is quantified via enzyme immunoassay (EIA) using a broadly specific antiserum that binds to all the major PG compounds. This assay includes human recombinant COX-2 and is an excellent tool which can be used for general inhibitor screening, or to eliminate false positive leads generated by less specific methods.  

     

    Brand:
    Cayman
    SKU:701080 - 96 wells

    Available on backorder

  • Immunogen: Synthetic peptide from the C-terminal region of human COX-2 • Host: Mouse • Species Reactivity: (+) Human, ovine; (-) Mouse, rat • Cross Reactivity: (-) COX-1 • Applications: IHC, WB  

     

    Brand:
    Cayman
    SKU:160112- 1 ea
  • Cyclooxygenase 2 (COX-2) is a bifunctional enzyme that exhibits both COX and peroxidase activities and catalyzes the first step in the biosynthesis of prostaglandins, thromboxanes, and prostacyclins.{500,501} The COX component converts arachidonic acid to the hydroperoxy endoperoxide prostaglandin G2 (PGG2; Item No. 17010), and the peroxidase component reduces the endoperoxide to the corresponding alcohol PGH2 (Item No. 17020). COX2 expression is induced by a variety of stimuli, including phorbol esters, LPS, and cytokines and is responsible for the biosynthesis of PGs under acute inflammatory conditions.{54420,14766} Thus, COX-2 has been the focus of attention for nonsteroidal anti-inflammatory drug (NSAID) development. Cayman’s COX-2 (human) Monoclonal Antibody (Clone CX229) can be used for immunohistochemistry (IHC) and Western blot (WB) applications. The antibody recognizes a unique C-terminal region of COX-2 that is not present in COX-1, specifically detecting COX-2 ~70 kDa from human and ovine samples.  

     

    Brand:
    Cayman
    SKU:160112 - 1 ea

    Available on backorder

  • Immunogen: Synthetic peptide from the C-terminal region of human COX-2 • Host: Mouse • Species Reactivity: (+) Human, ovine; (-) Mouse, rat • Cross Reactivity: (-) COX-1 • Applications: IHC, WB  

     

    Brand:
    Cayman
    SKU:160112- 1 ea

    Available on backorder

  • Immunogen: Peptide from the C-terminal region of human COX-2 • Host: Rabbit • Species Reactivity: (+) Human, mouse, and ovine • Species Reactivity: (−) COX-1 • Application(s): WB, IF • Expression of COX-2, the inducible form of COX, is regulated by growth factor tumors, tumor promoters, bacterial endotoxin, and cytokines  

     

    Brand:
    Cayman
    SKU:160107- 1 ea
  • COX-2 has been cloned from a variety of species including human, rat, and sheep and has a molecular weight of 72 kDa.{2,7,2884,4051}, COX-2 from these species are approximately 90% identical at the amino acid level, whereas the homology between COX-1 and COX-2 is only about 60%. Expression of COX-2 is regulated by growth factors, tumor promoters, bacterial endotoxin and cytokines, including IL-1β.{1528,1887} COX-2 is present in human breast tumors but is not expressed in normal breast tissue.{4154}  

     

    Brand:
    Cayman
    SKU:160107 - 1 ea

    Available on backorder

  • Immunogen: Peptide from the C-terminal region of human COX-2 • Host: Rabbit • Species Reactivity: (+) Human, mouse, and ovine • Species Reactivity: (−) COX-1 • Application(s): WB, IF • Expression of COX-2, the inducible form of COX, is regulated by growth factor tumors, tumor promoters, bacterial endotoxin, and cytokines  

     

    Brand:
    Cayman
    SKU:160107- 1 ea

    Available on backorder

  • Immunogen: A synthetic peptide from the C-terminal region of mouse/rat COX-2 • Host: Rabbit • Cross Reactivity: (−) COX-1 • Species Reactivity: (+) human, guinea pig, monkey, mouse, ovine, rabbit, and rat • Application(s): ICC, IF, IHC, and WB  

     

    Brand:
    Cayman
    SKU:160106- 1 ea
  • COX catalyzes the first step in the biosynthesis of prostaglandins, thromboxanes, and prostacyclins: the conversion of arachidonic acid to prostaglandin H2. Recent discoveries of the induction of COX by a variety of stimuli such as phorbol esters, lipopolysaccharides, and cytokines led to the hypothosis that the inducible form of COX, COX-2, is responsible for the biosynthesis of prostaglandins under acute inflammatory conditions.{4,3463} COX-2 is a 72 kDa protein which has been cloned from a variety of species including human, mouse, rat, and sheep.{2,7,2284,4051}  

     

    Brand:
    Cayman
    SKU:160106 - 1 ea

    Available on backorder

  • Immunogen: A synthetic peptide from the C-terminal region of mouse/rat COX-2 • Host: Rabbit • Cross Reactivity: (−) COX-1 • Species Reactivity: (+) human, guinea pig, monkey, mouse, ovine, rabbit, and rat • Application(s): ICC, IF, IHC, and WB  

     

    Brand:
    Cayman
    SKU:160106- 1 ea

    Available on backorder

  • Immunogen: Synthetic peptide from the C-terminal region of mouse COX-2 • Host: Rabbit • Cross Reactivity: (+) Human, macaque monkey, mouse, ovine, and rat COX-2; (−) COX-1 (all species); expected to react with bovine and canine COX-2 • Application(s): IF, IHC, and WB  

     

    Brand:
    Cayman
    SKU:160126- 1 ea
  • Cyclooxygenase (COX) catalyzes the first step in the biosynthesis of prostaglandins (PGs), thromboxanes, and prostacyclins: the conversion of arachidonic acid to PGH2. Recent discoveries of the induction of COX by a variety of stimuli such as phorbol esters, lipopolysaccharides, and cytokines led to the hypothesis that the inducible form of COX, COX-2, is responsible for the biosynthesis of PGs under acute inflammatory conditions.{4,3463} COX-2 is a 72 kDa protein which has been cloned from a variety of species including human, mouse, rat, and sheep.{2,7,2884,4051}  

     

    Brand:
    Cayman
    SKU:160126 - 1 ea

    Available on backorder

  • Immunogen: Synthetic peptide from the C-terminal region of mouse COX-2 • Host: Rabbit • Cross Reactivity: (+) Human, macaque monkey, mouse, ovine, and rat COX-2; (−) COX-1 (all species); expected to react with bovine and canine COX-2 • Application(s): IF, IHC, and WB  

     

    Brand:
    Cayman
    SKU:160126- 1 ea

    Available on backorder

  • The primary use of this antibody conjugate is for the detection of cyclooxygenase 2 (COX-2) in mouse samples by direct immunolabeling. COX catalyze the first step in the biosynthesis of prostaglandins (PGs), thromboxanes, and prostacyclins: the conversion of arachidonic acid to PGH2. Discoveries of the induction of COX by a variety of stimuli such as phorbol esters, lipopolysaccharides, and cytokines led to the hypothosis that the inducible form of COX, COX-2, is responsible for the biosynthesis of PGs under acute inflammatory conditions.{4,3463} COX-2 is a 72 kDa protein which has been cloned from a variety of species including human, mouse, rat, and sheep.{2,7,2284,4051}  

     

    Brand:
    Cayman
    SKU:10010096 - 1 ea

    Available on backorder

  • Immunogen: Synthetic peptide from the C-terminal region of mouse COX-2 · Host: Rabbit · Cross Reactivity: (−) COX-1 · Species Reactivity: (+) Human, mouse, and rat · Applications: FC, IF, and WB  

     

    Brand:
    Cayman
    SKU:10010096- 1 ea

    Available on backorder

  • Immunogen: Synthetic peptide from the C-terminal region of mouse COX-2 · Host: Rabbit · Cross Reactivity: (−) COX-1 · Species Reactivity: (+) Human, mouse, and rat · Applications: FC, IF, and WB  

     

    Brand:
    Cayman
    SKU:10010096- 1 ea
  • COX-1 and COX-2 catalyze the production of the prostaglandin (PG), thromboxane, and prostacyclin precursor PGH2. COX-2 is responsible for the biosynthesis of PGs under acute inflammatory conditions. This inducible COX-2 is believed to be the target enzyme for the anti-inflammatory activity of nonsteroidal anti-inflammatory drugs. The COX-2 (ovine) Inhibitor Screening Assay directly measures PGF2α (Item No. 16010) by SnCl2 reduction of COX-2-derived PGH2 (Item No. 17020) produced in the COX-2 reaction. The prostanoid product is quantified via enzyme immunoassay (EIA) using a broadly specific antiserum that binds to all the major PG compounds. This assay includes ovine COX-2 allowing the user to screen specific inhibitors. This assay is an excellent tool that can be used for general inhibitor screening, or to eliminate false positive leads generated by less specific methods.  

     

    Brand:
    Cayman
    SKU:702000 - 96 wells

    Available on backorder

  • Brand:
    Cayman
    SKU:20198- 50 µg

    Available on backorder

  • Cyclooxygenase catalyzes the first step in the biosynthesis of prostaglandins, thromboxanes, and prostacyclins: the conversion of arachidonic acid to prostaglandin H2. Recent discoveries of the induction of cyclooxygenase biosynthesis by a variety of stimuli such as phorbol esters, lipopolysaccharides, and cytokines led to the hypothesis that the inducible form of cyclooxygenase, COX-2, is responsible for the biosynthesis of prostaglandins under acute inflammatory conditions.{4} Cayman’s COX-2 monoclonal antibody (clone 12C10) can be used for ELISA, flow cytometry, immunofluorescence, and Western blot applications. The antibody recognizes COX-2 at 72 kDa from human, mouse, and ovine samples.  

     

    Brand:
    Cayman
    SKU:20198 - 50 µg

    Available on backorder

  • Immunogen: Synthetic peptide from the C-terminal region of human COX-2 • Host: Mouse, clone CX229 • Species Reactivity: (+) human, ovine; (−) mouse, rat, rabbit • Cross Reactivity: (−) COX-1 • Application(s): FC, ICC, IF • Isotype: IgG1 • This product is derived by labeling the COX-2 monoclonal antibody  

     

    Brand:
    Cayman
    SKU:160113- 1 ea
  • This product is derived by labeling the COX-2 monoclonal antibody (Item No. 160112) with fluorescein.  

     

    Brand:
    Cayman
    SKU:160113 - 1 ea

    Available on backorder

  • Immunogen: Synthetic peptide from the C-terminal region of human COX-2 • Host: Mouse, clone CX229 • Species Reactivity: (+) human, ovine; (−) mouse, rat, rabbit • Cross Reactivity: (−) COX-1 • Application(s): FC, ICC, IF • Isotype: IgG1 • This product is derived by labeling the COX-2 monoclonal antibody  

     

    Brand:
    Cayman
    SKU:160113- 1 ea

    Available on backorder

  • CP 154,526 is an antagonist of corticotropin-releasing factor receptor 1 (CRF1; Ki = 2.7 nM).{49085,49086} It is selective for CRF1 over CRF2 (Ki = >10 μM).{49085} CP 154,526 inhibits CRF-induced increases in adrenocorticotropic hormone (ACTH) levels in rat plasma with an ID50 value of 10 mg/kg. It increases the time spent in the open arms of the elevated plus maze in rats when administered at a dose of 1 mg/kg.{49087} CP 154,526 (10 mg/kg, twice per day for 14 days) decreases immobility time in the forced swim test in a rat model of depressive-like behavior.{49088} It also decreases stress-induced reinstatement of cocaine or heroin self-administration in cocaine- and heroin-trained rats, respectively, when administered at doses of 15 and 30 mg/kg.{49090}  

     

    Brand:
    Cayman
    SKU:20732 -

    Available on backorder

  • CP 154,526 is an antagonist of corticotropin-releasing factor receptor 1 (CRF1; Ki = 2.7 nM).{49085,49086} It is selective for CRF1 over CRF2 (Ki = >10 μM).{49085} CP 154,526 inhibits CRF-induced increases in adrenocorticotropic hormone (ACTH) levels in rat plasma with an ID50 value of 10 mg/kg. It increases the time spent in the open arms of the elevated plus maze in rats when administered at a dose of 1 mg/kg.{49087} CP 154,526 (10 mg/kg, twice per day for 14 days) decreases immobility time in the forced swim test in a rat model of depressive-like behavior.{49088} It also decreases stress-induced reinstatement of cocaine or heroin self-administration in cocaine- and heroin-trained rats, respectively, when administered at doses of 15 and 30 mg/kg.{49090}  

     

    Brand:
    Cayman
    SKU:20732 -

    Available on backorder

  • CP 154,526 is an antagonist of corticotropin-releasing factor receptor 1 (CRF1; Ki = 2.7 nM).{49085,49086} It is selective for CRF1 over CRF2 (Ki = >10 μM).{49085} CP 154,526 inhibits CRF-induced increases in adrenocorticotropic hormone (ACTH) levels in rat plasma with an ID50 value of 10 mg/kg. It increases the time spent in the open arms of the elevated plus maze in rats when administered at a dose of 1 mg/kg.{49087} CP 154,526 (10 mg/kg, twice per day for 14 days) decreases immobility time in the forced swim test in a rat model of depressive-like behavior.{49088} It also decreases stress-induced reinstatement of cocaine or heroin self-administration in cocaine- and heroin-trained rats, respectively, when administered at doses of 15 and 30 mg/kg.{49090}  

     

    Brand:
    Cayman
    SKU:20732 -

    Available on backorder

  • CP 154,526 is an antagonist of corticotropin-releasing factor receptor 1 (CRF1; Ki = 2.7 nM).{49085,49086} It is selective for CRF1 over CRF2 (Ki = >10 μM).{49085} CP 154,526 inhibits CRF-induced increases in adrenocorticotropic hormone (ACTH) levels in rat plasma with an ID50 value of 10 mg/kg. It increases the time spent in the open arms of the elevated plus maze in rats when administered at a dose of 1 mg/kg.{49087} CP 154,526 (10 mg/kg, twice per day for 14 days) decreases immobility time in the forced swim test in a rat model of depressive-like behavior.{49088} It also decreases stress-induced reinstatement of cocaine or heroin self-administration in cocaine- and heroin-trained rats, respectively, when administered at doses of 15 and 30 mg/kg.{49090}  

     

    Brand:
    Cayman
    SKU:20732 -

    Available on backorder

  • Essential fatty acid deficiency symptoms include immune system depression and a general state of inflammatory inhibition. CP 24,879 is an inhibitor of arachidonic acid biosynthesis acting via the inhibition of Δ5/Δ6 desaturase.{10907} Mice injected with CP 24,879 at 3 mg/kg had a reduction of liver arachidonate content of approximately 50%. Murine mastocytoma cells treated with 5 µM CP 24,879 showed increased mead acid content and nearly complete ablation of leukotriene C4 synthesis, consistent with a desaturase inhibition-induced state of essential fatty acid deficiency.{10906}  

     

    Brand:
    Cayman
    SKU:10120 - 1 mg

    Available on backorder

  • Essential fatty acid deficiency symptoms include immune system depression and a general state of inflammatory inhibition. CP 24,879 is an inhibitor of arachidonic acid biosynthesis acting via the inhibition of Δ5/Δ6 desaturase.{10907} Mice injected with CP 24,879 at 3 mg/kg had a reduction of liver arachidonate content of approximately 50%. Murine mastocytoma cells treated with 5 µM CP 24,879 showed increased mead acid content and nearly complete ablation of leukotriene C4 synthesis, consistent with a desaturase inhibition-induced state of essential fatty acid deficiency.{10906}  

     

    Brand:
    Cayman
    SKU:10120 - 10 mg

    Available on backorder

  • Essential fatty acid deficiency symptoms include immune system depression and a general state of inflammatory inhibition. CP 24,879 is an inhibitor of arachidonic acid biosynthesis acting via the inhibition of Δ5/Δ6 desaturase.{10907} Mice injected with CP 24,879 at 3 mg/kg had a reduction of liver arachidonate content of approximately 50%. Murine mastocytoma cells treated with 5 µM CP 24,879 showed increased mead acid content and nearly complete ablation of leukotriene C4 synthesis, consistent with a desaturase inhibition-induced state of essential fatty acid deficiency.{10906}  

     

    Brand:
    Cayman
    SKU:10120 - 5 mg

    Available on backorder

  • Essential fatty acid deficiency symptoms include immune system depression and a general state of inflammatory inhibition. CP 24,879 is an inhibitor of arachidonic acid biosynthesis acting via the inhibition of Δ5/Δ6 desaturase.{10907} Mice injected with CP 24,879 at 3 mg/kg had a reduction of liver arachidonate content of approximately 50%. Murine mastocytoma cells treated with 5 µM CP 24,879 showed increased mead acid content and nearly complete ablation of leukotriene C4 synthesis, consistent with a desaturase inhibition-induced state of essential fatty acid deficiency.{10906}  

     

    Brand:
    Cayman
    SKU:10120 - 50 mg

    Available on backorder

  • CP 31,398 is a p53 stabilizing agent.{42846} It increases active mutant p53 and p53 reporter gene expression without increasing total protein levels of p53 in H1299 lung cancer cells transfected with mutant p53. CP 31,398 is cytotoxic to a panel of 12 human glioma cell lines expressing wild-type or mutant p53 (EC50s = 11.2-22.2 μM).{42847} In vivo, CP 31,398 (100 mg/kg) decreases tumor growth by 50% in an A375.S2 melanoma mouse xenograft model and completely inhibits tumor growth in a DLD-1 colon cancer mouse xenograft model.{42846} Dietary administration of CP 31,398 (50 and 100 ppm) suppresses lung adenocarcinoma formation in a mouse model of tobacco carcinogen-induced lung adenoma and adenocarcinoma formation.{42848}  

     

    Brand:
    Cayman
    SKU:27455 - 1 mg

    Available on backorder

  • CP 31,398 is a p53 stabilizing agent.{42846} It increases active mutant p53 and p53 reporter gene expression without increasing total protein levels of p53 in H1299 lung cancer cells transfected with mutant p53. CP 31,398 is cytotoxic to a panel of 12 human glioma cell lines expressing wild-type or mutant p53 (EC50s = 11.2-22.2 μM).{42847} In vivo, CP 31,398 (100 mg/kg) decreases tumor growth by 50% in an A375.S2 melanoma mouse xenograft model and completely inhibits tumor growth in a DLD-1 colon cancer mouse xenograft model.{42846} Dietary administration of CP 31,398 (50 and 100 ppm) suppresses lung adenocarcinoma formation in a mouse model of tobacco carcinogen-induced lung adenoma and adenocarcinoma formation.{42848}  

     

    Brand:
    Cayman
    SKU:27455 - 10 mg

    Available on backorder

  • CP 31,398 is a p53 stabilizing agent.{42846} It increases active mutant p53 and p53 reporter gene expression without increasing total protein levels of p53 in H1299 lung cancer cells transfected with mutant p53. CP 31,398 is cytotoxic to a panel of 12 human glioma cell lines expressing wild-type or mutant p53 (EC50s = 11.2-22.2 μM).{42847} In vivo, CP 31,398 (100 mg/kg) decreases tumor growth by 50% in an A375.S2 melanoma mouse xenograft model and completely inhibits tumor growth in a DLD-1 colon cancer mouse xenograft model.{42846} Dietary administration of CP 31,398 (50 and 100 ppm) suppresses lung adenocarcinoma formation in a mouse model of tobacco carcinogen-induced lung adenoma and adenocarcinoma formation.{42848}  

     

    Brand:
    Cayman
    SKU:27455 - 5 mg

    Available on backorder

  • CP 376,395 is an antagonist of corticotropin-releasing factor (CRF) receptor 1 (CRF1; IC50 = 5.1 nM).{52114} It inhibits adenylate cyclase activity stimulated by ovine CRF in rat cerebral cortex and at human CRF1 receptors. CP 376,395 (17.8 mg/kg) inhibits CRF-induced increases in the acoustic startle response in rats. It increases the percentage of open arm entries and time spent in the open arms of the elevated plus maze in mice when administered via intramedial prefrontal cortical injection at doses of 1.5 and 3 nmol.{52113} CP 376,395 (10 mg/kg) reduces ethanol consumption in rats trained on an intermittent access schedule.{52112} It increases pulmonary ventilation in rats under normocapnic and hypercapnic conditions when injected into the locus coeruleus at a dose of 5 nmol/0.1 μl.{52111}  

     

    Brand:
    Cayman
    SKU:29188 - 1 mg

    Available on backorder

  • CP 376,395 is an antagonist of corticotropin-releasing factor (CRF) receptor 1 (CRF1; IC50 = 5.1 nM).{52114} It inhibits adenylate cyclase activity stimulated by ovine CRF in rat cerebral cortex and at human CRF1 receptors. CP 376,395 (17.8 mg/kg) inhibits CRF-induced increases in the acoustic startle response in rats. It increases the percentage of open arm entries and time spent in the open arms of the elevated plus maze in mice when administered via intramedial prefrontal cortical injection at doses of 1.5 and 3 nmol.{52113} CP 376,395 (10 mg/kg) reduces ethanol consumption in rats trained on an intermittent access schedule.{52112} It increases pulmonary ventilation in rats under normocapnic and hypercapnic conditions when injected into the locus coeruleus at a dose of 5 nmol/0.1 μl.{52111}  

     

    Brand:
    Cayman
    SKU:29188 - 10 mg

    Available on backorder

  • CP 376,395 is an antagonist of corticotropin-releasing factor (CRF) receptor 1 (CRF1; IC50 = 5.1 nM).{52114} It inhibits adenylate cyclase activity stimulated by ovine CRF in rat cerebral cortex and at human CRF1 receptors. CP 376,395 (17.8 mg/kg) inhibits CRF-induced increases in the acoustic startle response in rats. It increases the percentage of open arm entries and time spent in the open arms of the elevated plus maze in mice when administered via intramedial prefrontal cortical injection at doses of 1.5 and 3 nmol.{52113} CP 376,395 (10 mg/kg) reduces ethanol consumption in rats trained on an intermittent access schedule.{52112} It increases pulmonary ventilation in rats under normocapnic and hypercapnic conditions when injected into the locus coeruleus at a dose of 5 nmol/0.1 μl.{52111}  

     

    Brand:
    Cayman
    SKU:29188 - 5 mg

    Available on backorder

  • CP 466,722 is an inhibitor of ataxia-telangiectasia mutated (ATM) kinase that inhibits ionizing radiation-induced ATM autophosphorylation and phosphorylation of the ATM targets SMC1, Chk2, and p53 in HeLa cells when used at a concentration of 10 μM.{36744} It is selective for ATM over PI3K and PIKK in HFF(hTERT) and A-T(hTERT) fibroblasts, respectively. CP 466,722 decreases cell survival in response to ionizing radiation in HeLa cells. It is also cytotoxic to MCF-7 and SKBr-3 breast cancer cells (IC50s = 16.92 and 12.78 μM, respectively).{36744}  

     

    Brand:
    Cayman
    SKU:25417 - 1 mg

    Available on backorder

  • CP 466,722 is an inhibitor of ataxia-telangiectasia mutated (ATM) kinase that inhibits ionizing radiation-induced ATM autophosphorylation and phosphorylation of the ATM targets SMC1, Chk2, and p53 in HeLa cells when used at a concentration of 10 μM.{36744} It is selective for ATM over PI3K and PIKK in HFF(hTERT) and A-T(hTERT) fibroblasts, respectively. CP 466,722 decreases cell survival in response to ionizing radiation in HeLa cells. It is also cytotoxic to MCF-7 and SKBr-3 breast cancer cells (IC50s = 16.92 and 12.78 μM, respectively).{36744}  

     

    Brand:
    Cayman
    SKU:25417 - 10 mg

    Available on backorder

  • CP 466,722 is an inhibitor of ataxia-telangiectasia mutated (ATM) kinase that inhibits ionizing radiation-induced ATM autophosphorylation and phosphorylation of the ATM targets SMC1, Chk2, and p53 in HeLa cells when used at a concentration of 10 μM.{36744} It is selective for ATM over PI3K and PIKK in HFF(hTERT) and A-T(hTERT) fibroblasts, respectively. CP 466,722 decreases cell survival in response to ionizing radiation in HeLa cells. It is also cytotoxic to MCF-7 and SKBr-3 breast cancer cells (IC50s = 16.92 and 12.78 μM, respectively).{36744}  

     

    Brand:
    Cayman
    SKU:25417 - 25 mg

    Available on backorder

  • CP 466,722 is an inhibitor of ataxia-telangiectasia mutated (ATM) kinase that inhibits ionizing radiation-induced ATM autophosphorylation and phosphorylation of the ATM targets SMC1, Chk2, and p53 in HeLa cells when used at a concentration of 10 μM.{36744} It is selective for ATM over PI3K and PIKK in HFF(hTERT) and A-T(hTERT) fibroblasts, respectively. CP 466,722 decreases cell survival in response to ionizing radiation in HeLa cells. It is also cytotoxic to MCF-7 and SKBr-3 breast cancer cells (IC50s = 16.92 and 12.78 μM, respectively).{36744}  

     

    Brand:
    Cayman
    SKU:25417 - 5 mg

    Available on backorder

  • CP 47,497-C6-homolog is a synthetic cannabinoid (CB) whose alkyl chain consists of six carbons. While in vitro data suggest that alkylaminoindoles with a side chain length of C4 to C6 possess equal or higher affinity to the CB central CB1 and peripheral CB2 receptors compared to Δ9-THC, the properties of this compound have not been evaluated.{18621,16403} This product is intended for research and forensic applications.  

     

    Brand:
    Cayman
    SKU:9001448 - 1 mg

    Available on backorder

  • CP 47,497-C6-homolog is a synthetic cannabinoid (CB) whose alkyl chain consists of six carbons. While in vitro data suggest that alkylaminoindoles with a side chain length of C4 to C6 possess equal or higher affinity to the CB central CB1 and peripheral CB2 receptors compared to Δ9-THC, the properties of this compound have not been evaluated.{18621,16403} This product is intended for research and forensic applications.  

     

    Brand:
    Cayman
    SKU:9001448 - 10 mg

    Available on backorder

  • CP 47,497-C6-homolog is a synthetic cannabinoid (CB) whose alkyl chain consists of six carbons. While in vitro data suggest that alkylaminoindoles with a side chain length of C4 to C6 possess equal or higher affinity to the CB central CB1 and peripheral CB2 receptors compared to Δ9-THC, the properties of this compound have not been evaluated.{18621,16403} This product is intended for research and forensic applications.  

     

    Brand:
    Cayman
    SKU:9001448 - 5 mg

    Available on backorder

  • CP 47,497-C8-homolog is similar to CP 47,497, a monophenol synthetic cannabinoid (CB) that potently imitates natural CBs. CP 47,497-C8-homolog avidly binds the CB1 receptor (Ki = 0.83 nM).{6746} It has been identified as an adulterant of herbal blends.{18621} CP 47,497-C8-homolog C-8-hydroxy metabolite is a potential metabolite of CP 47,497-C8-homolog. This product is intended for forensic purposes.  

     

    Brand:
    Cayman
    SKU:9000773 - 1 mg

    Available on backorder

  • CP 47,497-C8-homolog is similar to CP 47,497, a monophenol synthetic cannabinoid (CB) that potently imitates natural CBs. CP 47,497-C8-homolog avidly binds the CB1 receptor (Ki = 0.83 nM).{6746} It has been identified as an adulterant of herbal blends.{18621} CP 47,497-C8-homolog C-8-hydroxy metabolite is a potential metabolite of CP 47,497-C8-homolog. This product is intended for forensic purposes.  

     

    Brand:
    Cayman
    SKU:9000773 - 100 µg

    Available on backorder

  • CP 47,497-C8-homolog is similar to CP 47,497, a monophenol synthetic cannabinoid (CB) that potently imitates natural CBs. CP 47,497-C8-homolog avidly binds the CB1 receptor (Ki = 0.83 nM).{6746} It has been identified as an adulterant of herbal blends.{18621} CP 47,497-C8-homolog C-8-hydroxy metabolite is a potential metabolite of CP 47,497-C8-homolog. This product is intended for forensic purposes.  

     

    Brand:
    Cayman
    SKU:9000773 - 500 µg

    Available on backorder

  • CP 47,497-C9-homolog is a synthetic cannabinoid (CB) whose alkyl chain consists of nine carbons. While in vitro data suggest that alkylaminoindoles with a side chain length of C4 to C6 possess equal or higher affinity to the central CB1 and peripheral CB2 receptors compared to Δ9-THC, the properties of this compound have not been evaluated.{18621,16797} This product is intended for research and forensic applications.  

     

    Brand:
    Cayman
    SKU:9001449 - 1 mg

    Available on backorder

  • CP 47,497-C9-homolog is a synthetic cannabinoid (CB) whose alkyl chain consists of nine carbons. While in vitro data suggest that alkylaminoindoles with a side chain length of C4 to C6 possess equal or higher affinity to the central CB1 and peripheral CB2 receptors compared to Δ9-THC, the properties of this compound have not been evaluated.{18621,16797} This product is intended for research and forensic applications.  

     

    Brand:
    Cayman
    SKU:9001449 - 10 mg

    Available on backorder

  • CP 47,497-C9-homolog is a synthetic cannabinoid (CB) whose alkyl chain consists of nine carbons. While in vitro data suggest that alkylaminoindoles with a side chain length of C4 to C6 possess equal or higher affinity to the central CB1 and peripheral CB2 receptors compared to Δ9-THC, the properties of this compound have not been evaluated.{18621,16797} This product is intended for research and forensic applications.  

     

    Brand:
    Cayman
    SKU:9001449 - 5 mg

    Available on backorder

  • CP 471,474 is a broad-spectrum inhibitor of matrix metalloproteinases (MMPs) with IC50 values of 0.7, 16, 13, and 0.9 nM for MMP-2, MMP-3, MMP-9, and MMP-13, respectively.{52163} It is selective for these MMPs over MMP-1 (IC50 = 1,170 nM). CP 471,474 reduces left ventricular enlargement and decreases the incidence of cardiac rupture in mouse models of myocardial infarction when administered at doses of 120 mg/kg twice per day and 240 mg/kg per day, respectively.{52163,52164}  

     

    Brand:
    Cayman
    SKU:29442 - 1 mg

    Available on backorder

  • CP 471,474 is a broad-spectrum inhibitor of matrix metalloproteinases (MMPs) with IC50 values of 0.7, 16, 13, and 0.9 nM for MMP-2, MMP-3, MMP-9, and MMP-13, respectively.{52163} It is selective for these MMPs over MMP-1 (IC50 = 1,170 nM). CP 471,474 reduces left ventricular enlargement and decreases the incidence of cardiac rupture in mouse models of myocardial infarction when administered at doses of 120 mg/kg twice per day and 240 mg/kg per day, respectively.{52163,52164}  

     

    Brand:
    Cayman
    SKU:29442 - 10 mg

    Available on backorder

  • CP 471,474 is a broad-spectrum inhibitor of matrix metalloproteinases (MMPs) with IC50 values of 0.7, 16, 13, and 0.9 nM for MMP-2, MMP-3, MMP-9, and MMP-13, respectively.{52163} It is selective for these MMPs over MMP-1 (IC50 = 1,170 nM). CP 471,474 reduces left ventricular enlargement and decreases the incidence of cardiac rupture in mouse models of myocardial infarction when administered at doses of 120 mg/kg twice per day and 240 mg/kg per day, respectively.{52163,52164}  

     

    Brand:
    Cayman
    SKU:29442 - 5 mg

    Available on backorder

  • CP 544,326 is a potent agonist of E prostanoid (EP) receptor 2 (IC50s = 10 and 15 nM for human and rat EP2, respectively).{38442} It is selective for EP2 over other EP receptors (IC50s = >3,200 nM for EP1, EP3, and EP4) and a panel of 37 G protein-coupled receptors (≤30% inhibition at a concentration of 10 μM). CP 544,326 increases cAMP levels in HEK293 cells expressing human EP2 (EC50 = 2.8 nM). CP 544,326 has poor corneal permeability in an ex vivo rabbit corneal model. However, PF-04217329, a cell-permeable prodrug form of CP 544,326, reduces intraocular pressure in rabbit, canine, and marmoset models of glaucoma.  

     

    Brand:
    Cayman
    SKU:22945 - 1 mg

    Available on backorder

  • CP 544,326 is a potent agonist of E prostanoid (EP) receptor 2 (IC50s = 10 and 15 nM for human and rat EP2, respectively).{38442} It is selective for EP2 over other EP receptors (IC50s = >3,200 nM for EP1, EP3, and EP4) and a panel of 37 G protein-coupled receptors (≤30% inhibition at a concentration of 10 μM). CP 544,326 increases cAMP levels in HEK293 cells expressing human EP2 (EC50 = 2.8 nM). CP 544,326 has poor corneal permeability in an ex vivo rabbit corneal model. However, PF-04217329, a cell-permeable prodrug form of CP 544,326, reduces intraocular pressure in rabbit, canine, and marmoset models of glaucoma.  

     

    Brand:
    Cayman
    SKU:22945 - 10 mg

    Available on backorder

  • CP 544,326 is a potent agonist of E prostanoid (EP) receptor 2 (IC50s = 10 and 15 nM for human and rat EP2, respectively).{38442} It is selective for EP2 over other EP receptors (IC50s = >3,200 nM for EP1, EP3, and EP4) and a panel of 37 G protein-coupled receptors (≤30% inhibition at a concentration of 10 μM). CP 544,326 increases cAMP levels in HEK293 cells expressing human EP2 (EC50 = 2.8 nM). CP 544,326 has poor corneal permeability in an ex vivo rabbit corneal model. However, PF-04217329, a cell-permeable prodrug form of CP 544,326, reduces intraocular pressure in rabbit, canine, and marmoset models of glaucoma.  

     

    Brand:
    Cayman
    SKU:22945 - 25 mg

    Available on backorder

  • CP 544,326 is a potent agonist of E prostanoid (EP) receptor 2 (IC50s = 10 and 15 nM for human and rat EP2, respectively).{38442} It is selective for EP2 over other EP receptors (IC50s = >3,200 nM for EP1, EP3, and EP4) and a panel of 37 G protein-coupled receptors (≤30% inhibition at a concentration of 10 μM). CP 544,326 increases cAMP levels in HEK293 cells expressing human EP2 (EC50 = 2.8 nM). CP 544,326 has poor corneal permeability in an ex vivo rabbit corneal model. However, PF-04217329, a cell-permeable prodrug form of CP 544,326, reduces intraocular pressure in rabbit, canine, and marmoset models of glaucoma.  

     

    Brand:
    Cayman
    SKU:22945 - 5 mg

    Available on backorder

  • CP 547,632 is an orally bioavailable and potent inhibitor of the receptor tyrosine kinases VEGF receptor 2 (VEGFR2) and basic fibroblast growth factor (bFGF) with IC50 values of 11 and 9 nM, respectively, in an enzyme assay.{38241} It is selective for VEGFR2 and bFGF over EGFR, PDGF receptor β (PDGFRβ), and related tyrosine kinases. CP 547,632 inhibits VEGFR2 autophosphorylation induced by VEGF in porcine aortic endothelial cells transfected with VEGFR2 (IC50 = 6 nM) and in a xenograft mouse model using NIH3T3/H-Ras cells (EC50 = 590 nM). It decreases angiogenesis induced by VEGF or bFGF and suppresses tumor growth in athymic mice.  

     

    Brand:
    Cayman
    SKU:21773 -

    Out of stock

  • CP 547,632 is an orally bioavailable and potent inhibitor of the receptor tyrosine kinases VEGF receptor 2 (VEGFR2) and basic fibroblast growth factor (bFGF) with IC50 values of 11 and 9 nM, respectively, in an enzyme assay.{38241} It is selective for VEGFR2 and bFGF over EGFR, PDGF receptor β (PDGFRβ), and related tyrosine kinases. CP 547,632 inhibits VEGFR2 autophosphorylation induced by VEGF in porcine aortic endothelial cells transfected with VEGFR2 (IC50 = 6 nM) and in a xenograft mouse model using NIH3T3/H-Ras cells (EC50 = 590 nM). It decreases angiogenesis induced by VEGF or bFGF and suppresses tumor growth in athymic mice.  

     

    Brand:
    Cayman
    SKU:21773 -

    Out of stock

  • CP 547,632 is an orally bioavailable and potent inhibitor of the receptor tyrosine kinases VEGF receptor 2 (VEGFR2) and basic fibroblast growth factor (bFGF) with IC50 values of 11 and 9 nM, respectively, in an enzyme assay.{38241} It is selective for VEGFR2 and bFGF over EGFR, PDGF receptor β (PDGFRβ), and related tyrosine kinases. CP 547,632 inhibits VEGFR2 autophosphorylation induced by VEGF in porcine aortic endothelial cells transfected with VEGFR2 (IC50 = 6 nM) and in a xenograft mouse model using NIH3T3/H-Ras cells (EC50 = 590 nM). It decreases angiogenesis induced by VEGF or bFGF and suppresses tumor growth in athymic mice.  

     

    Brand:
    Cayman
    SKU:21773 -

    Out of stock

  • Acetyl-CoA carboxylase (ACC) is a key enzyme of fatty acid metabolism that enables the synthesis of malonyl-CoA, a precursor for fatty acids. CP 640,186 is an isozyme-nonselective ACC inhibitor with IC50 values of 53 and 61 nM for rat liver ACC1 and rat skeletal muscle ACC2, respectively.{31019} It has been shown to lower malonyl-CoA levels and to inhibit hepatic fatty acid and triglyceride synthesis both in vitro and in vivo.{31019} CP 640,186 can also stimulate muscle fatty acid oxidation (EC50 = 1.3 µM in rat epitrochlearis muscle strips) and lower whole body respiratory quotient in rats (ED50 = ~30 mg/kg).{31019}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Acetyl-CoA carboxylase (ACC) is a key enzyme of fatty acid metabolism that enables the synthesis of malonyl-CoA, a precursor for fatty acids. CP 640,186 is an isozyme-nonselective ACC inhibitor with IC50 values of 53 and 61 nM for rat liver ACC1 and rat skeletal muscle ACC2, respectively.{31019} It has been shown to lower malonyl-CoA levels and to inhibit hepatic fatty acid and triglyceride synthesis both in vitro and in vivo.{31019} CP 640,186 can also stimulate muscle fatty acid oxidation (EC50 = 1.3 µM in rat epitrochlearis muscle strips) and lower whole body respiratory quotient in rats (ED50 = ~30 mg/kg).{31019}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Acetyl-CoA carboxylase (ACC) is a key enzyme of fatty acid metabolism that enables the synthesis of malonyl-CoA, a precursor for fatty acids. CP 640,186 is an isozyme-nonselective ACC inhibitor with IC50 values of 53 and 61 nM for rat liver ACC1 and rat skeletal muscle ACC2, respectively.{31019} It has been shown to lower malonyl-CoA levels and to inhibit hepatic fatty acid and triglyceride synthesis both in vitro and in vivo.{31019} CP 640,186 can also stimulate muscle fatty acid oxidation (EC50 = 1.3 µM in rat epitrochlearis muscle strips) and lower whole body respiratory quotient in rats (ED50 = ~30 mg/kg).{31019}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Acetyl-CoA carboxylase (ACC) is a key enzyme of fatty acid metabolism that enables the synthesis of malonyl-CoA, a precursor for fatty acids. CP 640,186 is an isozyme-nonselective ACC inhibitor with IC50 values of 53 and 61 nM for rat liver ACC1 and rat skeletal muscle ACC2, respectively.{31019} It has been shown to lower malonyl-CoA levels and to inhibit hepatic fatty acid and triglyceride synthesis both in vitro and in vivo.{31019} CP 640,186 can also stimulate muscle fatty acid oxidation (EC50 = 1.3 µM in rat epitrochlearis muscle strips) and lower whole body respiratory quotient in rats (ED50 = ~30 mg/kg).{31019}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CP 671,305 is a potent inhibitor of phosphodiesterase 4D (PDE4D; IC50 = 3 nM).{46489} It is selective for PDE4D over PDE4A, -B, and -C (IC50s = 310, 287, and 3,858 nM, respectively), as well as over PDE1-3 and 5 (IC50s = >5,000 nM for all). CP 671,305 inhibits release of leukotriene E4 (LTE4; Item No. 20410) from eosinophils (IC50 = 52 nM) and LTB4 (Item No. 20110) from neutrophils (IC50 = 106 nM). In vivo, CP 671,305 inhibits antigen-induced pulmonary eosinophil influx in cynomolgus monkeys in a dose-dependent manner.  

     

    Brand:
    Cayman
    SKU:26743 - 1 mg

    Available on backorder

  • CP 671,305 is a potent inhibitor of phosphodiesterase 4D (PDE4D; IC50 = 3 nM).{46489} It is selective for PDE4D over PDE4A, -B, and -C (IC50s = 310, 287, and 3,858 nM, respectively), as well as over PDE1-3 and 5 (IC50s = >5,000 nM for all). CP 671,305 inhibits release of leukotriene E4 (LTE4; Item No. 20410) from eosinophils (IC50 = 52 nM) and LTB4 (Item No. 20110) from neutrophils (IC50 = 106 nM). In vivo, CP 671,305 inhibits antigen-induced pulmonary eosinophil influx in cynomolgus monkeys in a dose-dependent manner.  

     

    Brand:
    Cayman
    SKU:26743 - 10 mg

    Available on backorder

  • CP 671,305 is a potent inhibitor of phosphodiesterase 4D (PDE4D; IC50 = 3 nM).{46489} It is selective for PDE4D over PDE4A, -B, and -C (IC50s = 310, 287, and 3,858 nM, respectively), as well as over PDE1-3 and 5 (IC50s = >5,000 nM for all). CP 671,305 inhibits release of leukotriene E4 (LTE4; Item No. 20410) from eosinophils (IC50 = 52 nM) and LTB4 (Item No. 20110) from neutrophils (IC50 = 106 nM). In vivo, CP 671,305 inhibits antigen-induced pulmonary eosinophil influx in cynomolgus monkeys in a dose-dependent manner.  

     

    Brand:
    Cayman
    SKU:26743 - 5 mg

    Available on backorder

  • CP-673,451 is a selective inhibitor of the platelet-derived growth factor receptor β (PDGFRβ) kinase with an IC50 value of 1 nM.{30922} It also inhibits the PDGFRα kinase (IC50 = 10 nM), but exhibits greater than 450-fold selectivity over other angiogenic receptors such as VEGFR 2, TIE-2, and FGR2.{30922} In several in vivo tumor models, CP-673,451 has antiangiogenic and antitumor activity.{30922,30923,30921}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CP-673,451 is a selective inhibitor of the platelet-derived growth factor receptor β (PDGFRβ) kinase with an IC50 value of 1 nM.{30922} It also inhibits the PDGFRα kinase (IC50 = 10 nM), but exhibits greater than 450-fold selectivity over other angiogenic receptors such as VEGFR 2, TIE-2, and FGR2.{30922} In several in vivo tumor models, CP-673,451 has antiangiogenic and antitumor activity.{30922,30923,30921}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CP-673,451 is a selective inhibitor of the platelet-derived growth factor receptor β (PDGFRβ) kinase with an IC50 value of 1 nM.{30922} It also inhibits the PDGFRα kinase (IC50 = 10 nM), but exhibits greater than 450-fold selectivity over other angiogenic receptors such as VEGFR 2, TIE-2, and FGR2.{30922} In several in vivo tumor models, CP-673,451 has antiangiogenic and antitumor activity.{30922,30923,30921}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CP 690,550 is a potent, cell-permeable inhibitor of all JAK isoforms (IC50s = 6.1, 12, and 8 nM for JAK1, JAK2, and JAK3, respectively).{22678} It is selective for JAK1-3 over ROCK-II and Lck (IC50s = 3,400 and 3,870 nM, respectively) as well as 28 additional kinases in enzyme assays (IC50s = >10,000 nM). It inhibits IL-2-mediated phosphorylation of JAK3 and STAT5 when used at a concentration of 30 ng/ml.{22675} CP 690,550 prevents rejection and prolongs survival in murine and cynomolgus monkey models of heterotopic heart and kidney transplantation, respectively. Formulations containing CP 690,550 have been used in the prevention of organ allograft rejection as well as in the treatment of the inflammatory or autoimmune components of a host of diseases, including rheumatoid arthritis and ulcerative colitis.{22675,22677,22676,22679}  

     

    Brand:
    Cayman
    SKU:11598 - 10 mg

    Available on backorder

  • CP 690,550 is a potent, cell-permeable inhibitor of all JAK isoforms (IC50s = 6.1, 12, and 8 nM for JAK1, JAK2, and JAK3, respectively).{22678} It is selective for JAK1-3 over ROCK-II and Lck (IC50s = 3,400 and 3,870 nM, respectively) as well as 28 additional kinases in enzyme assays (IC50s = >10,000 nM). It inhibits IL-2-mediated phosphorylation of JAK3 and STAT5 when used at a concentration of 30 ng/ml.{22675} CP 690,550 prevents rejection and prolongs survival in murine and cynomolgus monkey models of heterotopic heart and kidney transplantation, respectively. Formulations containing CP 690,550 have been used in the prevention of organ allograft rejection as well as in the treatment of the inflammatory or autoimmune components of a host of diseases, including rheumatoid arthritis and ulcerative colitis.{22675,22677,22676,22679}  

     

    Brand:
    Cayman
    SKU:11598 - 25 mg

    Available on backorder

  • CP 690,550 is a potent, cell-permeable inhibitor of all JAK isoforms (IC50s = 6.1, 12, and 8 nM for JAK1, JAK2, and JAK3, respectively).{22678} It is selective for JAK1-3 over ROCK-II and Lck (IC50s = 3,400 and 3,870 nM, respectively) as well as 28 additional kinases in enzyme assays (IC50s = >10,000 nM). It inhibits IL-2-mediated phosphorylation of JAK3 and STAT5 when used at a concentration of 30 ng/ml.{22675} CP 690,550 prevents rejection and prolongs survival in murine and cynomolgus monkey models of heterotopic heart and kidney transplantation, respectively. Formulations containing CP 690,550 have been used in the prevention of organ allograft rejection as well as in the treatment of the inflammatory or autoimmune components of a host of diseases, including rheumatoid arthritis and ulcerative colitis.{22675,22677,22676,22679}  

     

    Brand:
    Cayman
    SKU:11598 - 5 mg

    Available on backorder

  • CP 690,550 is a potent, cell-permeable inhibitor of all JAK isoforms (IC50s = 6.1, 12, and 8 nM for JAK1, JAK2, and JAK3, respectively).{22678} It is selective for JAK1-3 over ROCK-II and Lck (IC50s = 3,400 and 3,870 nM, respectively) as well as 28 additional kinases in enzyme assays (IC50s = >10,000 nM). It inhibits IL-2-mediated phosphorylation of JAK3 and STAT5 when used at a concentration of 30 ng/ml.{22675} CP 690,550 prevents rejection and prolongs survival in murine and cynomolgus monkey models of heterotopic heart and kidney transplantation, respectively. Formulations containing CP 690,550 have been used in the prevention of organ allograft rejection as well as in the treatment of the inflammatory or autoimmune components of a host of diseases, including rheumatoid arthritis and ulcerative colitis.{22675,22677,22676,22679}  

     

    Brand:
    Cayman
    SKU:11598 - 50 mg

    Available on backorder

  • CP 724,714 is a selective inhibitor of HER2/ErbB2 with an IC50 value of 10 nM.{31036} It demonstrates greater than 640-fold selectivity against EGFR, InsR, IRG-1R, PDGFR, VEGFR2, Abl, Src, and c-Met.{31036} CP 724,714 has been shown to inhibit the proliferation of ErbB2-amplified cells, including BT474 and SK-BR-3 with IC50 values of 0.25 and 0.95 μM, respectively.{31036} It also demonstrates antitumor activity in various human tumor xenograft models.{31036} However, CP 724,714 was discontinued from clinical development due to hepatotoxicity caused by its ability to inhibit hepatic efflux transporters at low micromolar concentrations.{31035}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CP 724,714 is a selective inhibitor of HER2/ErbB2 with an IC50 value of 10 nM.{31036} It demonstrates greater than 640-fold selectivity against EGFR, InsR, IRG-1R, PDGFR, VEGFR2, Abl, Src, and c-Met.{31036} CP 724,714 has been shown to inhibit the proliferation of ErbB2-amplified cells, including BT474 and SK-BR-3 with IC50 values of 0.25 and 0.95 μM, respectively.{31036} It also demonstrates antitumor activity in various human tumor xenograft models.{31036} However, CP 724,714 was discontinued from clinical development due to hepatotoxicity caused by its ability to inhibit hepatic efflux transporters at low micromolar concentrations.{31035}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CP 724,714 is a selective inhibitor of HER2/ErbB2 with an IC50 value of 10 nM.{31036} It demonstrates greater than 640-fold selectivity against EGFR, InsR, IRG-1R, PDGFR, VEGFR2, Abl, Src, and c-Met.{31036} CP 724,714 has been shown to inhibit the proliferation of ErbB2-amplified cells, including BT474 and SK-BR-3 with IC50 values of 0.25 and 0.95 μM, respectively.{31036} It also demonstrates antitumor activity in various human tumor xenograft models.{31036} However, CP 724,714 was discontinued from clinical development due to hepatotoxicity caused by its ability to inhibit hepatic efflux transporters at low micromolar concentrations.{31035}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CP 724,714 is a selective inhibitor of HER2/ErbB2 with an IC50 value of 10 nM.{31036} It demonstrates greater than 640-fold selectivity against EGFR, InsR, IRG-1R, PDGFR, VEGFR2, Abl, Src, and c-Met.{31036} CP 724,714 has been shown to inhibit the proliferation of ErbB2-amplified cells, including BT474 and SK-BR-3 with IC50 values of 0.25 and 0.95 μM, respectively.{31036} It also demonstrates antitumor activity in various human tumor xenograft models.{31036} However, CP 724,714 was discontinued from clinical development due to hepatotoxicity caused by its ability to inhibit hepatic efflux transporters at low micromolar concentrations.{31035}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CP 775,146 is an agonist of peroxisome proliferator-activated receptor α (PPARα) that selectively binds to PPARα (Ki = 24.5 nM) over PPARβ and PPARγ (Kis = >10,000 nM).{51044} CP 775,146 induces PPARα transcriptional activity in a reporter assay (EC50s = 57 and 284 nM for human and rat receptors, respectively, expressed in HepG2 cells). It decreases plasma triglyceride levels in mice by 73% when administered at a dose of 2 mg/kg per day for two days.  

     

    Brand:
    Cayman
    SKU:28290 - 1 mg

    Available on backorder

  • CP 775,146 is an agonist of peroxisome proliferator-activated receptor α (PPARα) that selectively binds to PPARα (Ki = 24.5 nM) over PPARβ and PPARγ (Kis = >10,000 nM).{51044} CP 775,146 induces PPARα transcriptional activity in a reporter assay (EC50s = 57 and 284 nM for human and rat receptors, respectively, expressed in HepG2 cells). It decreases plasma triglyceride levels in mice by 73% when administered at a dose of 2 mg/kg per day for two days.  

     

    Brand:
    Cayman
    SKU:28290 - 10 mg

    Available on backorder

  • CP 775,146 is an agonist of peroxisome proliferator-activated receptor α (PPARα) that selectively binds to PPARα (Ki = 24.5 nM) over PPARβ and PPARγ (Kis = >10,000 nM).{51044} CP 775,146 induces PPARα transcriptional activity in a reporter assay (EC50s = 57 and 284 nM for human and rat receptors, respectively, expressed in HepG2 cells). It decreases plasma triglyceride levels in mice by 73% when administered at a dose of 2 mg/kg per day for two days.  

     

    Brand:
    Cayman
    SKU:28290 - 25 mg

    Available on backorder

  • CP 775,146 is an agonist of peroxisome proliferator-activated receptor α (PPARα) that selectively binds to PPARα (Ki = 24.5 nM) over PPARβ and PPARγ (Kis = >10,000 nM).{51044} CP 775,146 induces PPARα transcriptional activity in a reporter assay (EC50s = 57 and 284 nM for human and rat receptors, respectively, expressed in HepG2 cells). It decreases plasma triglyceride levels in mice by 73% when administered at a dose of 2 mg/kg per day for two days.  

     

    Brand:
    Cayman
    SKU:28290 - 5 mg

    Available on backorder

  • Phosphodiesterases (PDE) enzymatically convert the cyclic nucleotide second messengers cAMP and cGMP to 5’-AMP and 5’-GMP, respectively, thus terminating signal transduction. The cAMP-specific PDE4 isoforms may be particularly important in certain respiratory and neurological diseases. CP 80,633 is a selective inhibitor of PDE4 (IC50 = 1.27 μM for PDE4 versus. >100 μM for PDE1, PDE2, PDE3, and PDE5).{18129} It potentiates PGE1-dependent increases in cAMP levels in eosinophils, monocytes, and T-cells, inhibits eosinophil superoxide production (IC50 induced TNF-α release from monocytes (IC50 = 0.22 μM).{18129} CP 80,633 (1 mg/kg) significantly reduces antigen-induced airway inflammation in atopic guinea pigs, monkeys, and mice.{18130,18131}  

     

    Brand:
    Cayman
    SKU:-
  • Phosphodiesterases (PDE) enzymatically convert the cyclic nucleotide second messengers cAMP and cGMP to 5’-AMP and 5’-GMP, respectively, thus terminating signal transduction. The cAMP-specific PDE4 isoforms may be particularly important in certain respiratory and neurological diseases. CP 80,633 is a selective inhibitor of PDE4 (IC50 = 1.27 μM for PDE4 versus. >100 μM for PDE1, PDE2, PDE3, and PDE5).{18129} It potentiates PGE1-dependent increases in cAMP levels in eosinophils, monocytes, and T-cells, inhibits eosinophil superoxide production (IC50 induced TNF-α release from monocytes (IC50 = 0.22 μM).{18129} CP 80,633 (1 mg/kg) significantly reduces antigen-induced airway inflammation in atopic guinea pigs, monkeys, and mice.{18130,18131}  

     

    Brand:
    Cayman
    SKU:-
  • Phosphodiesterases (PDE) enzymatically convert the cyclic nucleotide second messengers cAMP and cGMP to 5’-AMP and 5’-GMP, respectively, thus terminating signal transduction. The cAMP-specific PDE4 isoforms may be particularly important in certain respiratory and neurological diseases. CP 80,633 is a selective inhibitor of PDE4 (IC50 = 1.27 μM for PDE4 versus. >100 μM for PDE1, PDE2, PDE3, and PDE5).{18129} It potentiates PGE1-dependent increases in cAMP levels in eosinophils, monocytes, and T-cells, inhibits eosinophil superoxide production (IC50 induced TNF-α release from monocytes (IC50 = 0.22 μM).{18129} CP 80,633 (1 mg/kg) significantly reduces antigen-induced airway inflammation in atopic guinea pigs, monkeys, and mice.{18130,18131}  

     

    Brand:
    Cayman
    SKU:-
  • Phosphodiesterases (PDE) enzymatically convert the cyclic nucleotide second messengers cAMP and cGMP to 5’-AMP and 5’-GMP, respectively, thus terminating signal transduction. The cAMP-specific PDE4 isoforms may be particularly important in certain respiratory and neurological diseases. CP 80,633 is a selective inhibitor of PDE4 (IC50 = 1.27 μM for PDE4 versus. >100 μM for PDE1, PDE2, PDE3, and PDE5).{18129} It potentiates PGE1-dependent increases in cAMP levels in eosinophils, monocytes, and T-cells, inhibits eosinophil superoxide production (IC50 induced TNF-α release from monocytes (IC50 = 0.22 μM).{18129} CP 80,633 (1 mg/kg) significantly reduces antigen-induced airway inflammation in atopic guinea pigs, monkeys, and mice.{18130,18131}  

     

    Brand:
    Cayman
    SKU:-
  • CP 91,149 is an inhibitor of human liver glycogen phosphorylase a (LGPa), muscle glycogen phosphorylase a (MGPa), and MGPb (IC50s = 0.13, 0.2, and 0.3 μM, respectively, in the presence of glucose).{41399,41400,41401} CP 91,149 is 5- to 10-fold less potent in the absence of glucose.{41399} In vitro, it inhibits glucagon-stimulated glycogenolysis in primary human hepatocytes (IC50 = 2.1 μM) and increases glycogen synthesis in rat hepatocytes at a concentration of 2.5 μM in the presence of 5 mM glucose.{41399,41401} CP 91,149 inhibits brain GP (IC50 = 0.5 μM) and, at a concentration of 30 μM, inhibits glycogen accumulation and proliferation of A549 non-small cell lung carcinoma (NSCLC) cells that express endogenous brain GP.{41402} In vivo, CP 91,149 (25 mg/kg, p.o.) lowers the plasma glucose level in diabetic ob/ob mice within 3 hours of administration without producing hypoglycemia, but has no effect on normoglycemic, non-diabetic mice.{41399}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CP 91,149 is an inhibitor of human liver glycogen phosphorylase a (LGPa), muscle glycogen phosphorylase a (MGPa), and MGPb (IC50s = 0.13, 0.2, and 0.3 μM, respectively, in the presence of glucose).{41399,41400,41401} CP 91,149 is 5- to 10-fold less potent in the absence of glucose.{41399} In vitro, it inhibits glucagon-stimulated glycogenolysis in primary human hepatocytes (IC50 = 2.1 μM) and increases glycogen synthesis in rat hepatocytes at a concentration of 2.5 μM in the presence of 5 mM glucose.{41399,41401} CP 91,149 inhibits brain GP (IC50 = 0.5 μM) and, at a concentration of 30 μM, inhibits glycogen accumulation and proliferation of A549 non-small cell lung carcinoma (NSCLC) cells that express endogenous brain GP.{41402} In vivo, CP 91,149 (25 mg/kg, p.o.) lowers the plasma glucose level in diabetic ob/ob mice within 3 hours of administration without producing hypoglycemia, but has no effect on normoglycemic, non-diabetic mice.{41399}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CP 91,149 is an inhibitor of human liver glycogen phosphorylase a (LGPa), muscle glycogen phosphorylase a (MGPa), and MGPb (IC50s = 0.13, 0.2, and 0.3 μM, respectively, in the presence of glucose).{41399,41400,41401} CP 91,149 is 5- to 10-fold less potent in the absence of glucose.{41399} In vitro, it inhibits glucagon-stimulated glycogenolysis in primary human hepatocytes (IC50 = 2.1 μM) and increases glycogen synthesis in rat hepatocytes at a concentration of 2.5 μM in the presence of 5 mM glucose.{41399,41401} CP 91,149 inhibits brain GP (IC50 = 0.5 μM) and, at a concentration of 30 μM, inhibits glycogen accumulation and proliferation of A549 non-small cell lung carcinoma (NSCLC) cells that express endogenous brain GP.{41402} In vivo, CP 91,149 (25 mg/kg, p.o.) lowers the plasma glucose level in diabetic ob/ob mice within 3 hours of administration without producing hypoglycemia, but has no effect on normoglycemic, non-diabetic mice.{41399}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CP 94,253 is an agonist of the serotonin (5-HT) receptor subtype 5-HT1B (Ki = 2 nM in a radioligand binding assay).{48735} It is selective for 5-HT1B over 5-HT1A, 5-HT1D, 5-HT1C, and 5-HT2 receptors (Kis = 89, 49, 860, and 1,600 nM, respectively). CP 94,253 (10 and 17 mg/kg) reduces aggressive behavior in a resident-intruder test in mice, as well as decreases alcohol-induced aggression in mice with an ED50 value of 3.8 mg/kg.{48736} It decreases the time mice spend immobile in the forced swim test by 43%, indicating antidepressant-like activity, when administered at a dose of 5 mg/kg.{48737} CP 94,253 (2.5 mg/kg) also increases drinking in the Vogel punished drinking task, indicating anxiolytic-like activity, in rats.{48738}  

     

    Brand:
    Cayman
    SKU:29486 - 10 mg

    Available on backorder

  • CP 94,253 is an agonist of the serotonin (5-HT) receptor subtype 5-HT1B (Ki = 2 nM in a radioligand binding assay).{48735} It is selective for 5-HT1B over 5-HT1A, 5-HT1D, 5-HT1C, and 5-HT2 receptors (Kis = 89, 49, 860, and 1,600 nM, respectively). CP 94,253 (10 and 17 mg/kg) reduces aggressive behavior in a resident-intruder test in mice, as well as decreases alcohol-induced aggression in mice with an ED50 value of 3.8 mg/kg.{48736} It decreases the time mice spend immobile in the forced swim test by 43%, indicating antidepressant-like activity, when administered at a dose of 5 mg/kg.{48737} CP 94,253 (2.5 mg/kg) also increases drinking in the Vogel punished drinking task, indicating anxiolytic-like activity, in rats.{48738}  

     

    Brand:
    Cayman
    SKU:29486 - 25 mg

    Available on backorder

  • CP 94,253 is an agonist of the serotonin (5-HT) receptor subtype 5-HT1B (Ki = 2 nM in a radioligand binding assay).{48735} It is selective for 5-HT1B over 5-HT1A, 5-HT1D, 5-HT1C, and 5-HT2 receptors (Kis = 89, 49, 860, and 1,600 nM, respectively). CP 94,253 (10 and 17 mg/kg) reduces aggressive behavior in a resident-intruder test in mice, as well as decreases alcohol-induced aggression in mice with an ED50 value of 3.8 mg/kg.{48736} It decreases the time mice spend immobile in the forced swim test by 43%, indicating antidepressant-like activity, when administered at a dose of 5 mg/kg.{48737} CP 94,253 (2.5 mg/kg) also increases drinking in the Vogel punished drinking task, indicating anxiolytic-like activity, in rats.{48738}  

     

    Brand:
    Cayman
    SKU:29486 - 5 mg

    Available on backorder

  • CP 945,598 (hydrochloride) is a selective antagonist of the cannabinoid receptor CB1 with a Ki value of 0.7 nM and demonstrates relatively low affinity for CB2 receptors (Ki = 7.6 µM).{32999,33000} It is reported to reverse cannabinoid agonist-mediated responses (i.e., hypo-locomotion, hypothermia, analgesia, and catalepsy), to reduce food intake, and to increase energy expenditure as well as fat oxidation in rats.{32999,33000}  

     

    Brand:
    Cayman
    SKU:11955 - 1 mg

    Available on backorder

  • CP 945,598 (hydrochloride) is a selective antagonist of the cannabinoid receptor CB1 with a Ki value of 0.7 nM and demonstrates relatively low affinity for CB2 receptors (Ki = 7.6 µM).{32999,33000} It is reported to reverse cannabinoid agonist-mediated responses (i.e., hypo-locomotion, hypothermia, analgesia, and catalepsy), to reduce food intake, and to increase energy expenditure as well as fat oxidation in rats.{32999,33000}  

     

    Brand:
    Cayman
    SKU:11955 - 10 mg

    Available on backorder

  • CP 945,598 (hydrochloride) is a selective antagonist of the cannabinoid receptor CB1 with a Ki value of 0.7 nM and demonstrates relatively low affinity for CB2 receptors (Ki = 7.6 µM).{32999,33000} It is reported to reverse cannabinoid agonist-mediated responses (i.e., hypo-locomotion, hypothermia, analgesia, and catalepsy), to reduce food intake, and to increase energy expenditure as well as fat oxidation in rats.{32999,33000}  

     

    Brand:
    Cayman
    SKU:11955 - 25 mg

    Available on backorder

  • CP 945,598 (hydrochloride) is a selective antagonist of the cannabinoid receptor CB1 with a Ki value of 0.7 nM and demonstrates relatively low affinity for CB2 receptors (Ki = 7.6 µM).{32999,33000} It is reported to reverse cannabinoid agonist-mediated responses (i.e., hypo-locomotion, hypothermia, analgesia, and catalepsy), to reduce food intake, and to increase energy expenditure as well as fat oxidation in rats.{32999,33000}  

     

    Brand:
    Cayman
    SKU:11955 - 5 mg

    Available on backorder

  • CP 99,994 is a nonpeptide neurokinin-1 (NK1) receptor antagonist (Ki = 0.25 nM in a radioligand binding assay).{46649} It is selective for NK1 over NK2 and NK3 receptors (Kis = >10 μM for both) as well as dopamine D1 and D2, α1-, α2- and β-adrenergic, serotonin, histamine H1, muscarinic and nicotinic acetylcholine, μ-opioid, glutamate, benzodiazepine, and γ-aminobutyric acid (GABA) receptors (IC50s = >1 μM for all). In vitro, CP 99,994 inhibits excitation of guinea pig locus coeruleus cells induced by substance P (Item No. 24035; IC50 = 25 nM). It inhibits increases in horizontal locomotor activity induced by the NK1 agonist [Sar9,Met(O2)11]-substance P in guinea pigs (ID50 = 0.59 mg/kg). CP 99,994 inhibits aerosolized capsaicin-induced plasma extravasation in guinea pig lung (ID50 = 4 mg/kg). It exhibits anti-emetic effects in ferret models of emesis induced by copper sulfate, loperamide, or cisplatin (Item No. 13119) when administered at doses of 0.3 and 1 mg/kg.{46650}  

     

    Brand:
    Cayman
    SKU:27669 - 1 mg

    Available on backorder

  • CP 99,994 is a nonpeptide neurokinin-1 (NK1) receptor antagonist (Ki = 0.25 nM in a radioligand binding assay).{46649} It is selective for NK1 over NK2 and NK3 receptors (Kis = >10 μM for both) as well as dopamine D1 and D2, α1-, α2- and β-adrenergic, serotonin, histamine H1, muscarinic and nicotinic acetylcholine, μ-opioid, glutamate, benzodiazepine, and γ-aminobutyric acid (GABA) receptors (IC50s = >1 μM for all). In vitro, CP 99,994 inhibits excitation of guinea pig locus coeruleus cells induced by substance P (Item No. 24035; IC50 = 25 nM). It inhibits increases in horizontal locomotor activity induced by the NK1 agonist [Sar9,Met(O2)11]-substance P in guinea pigs (ID50 = 0.59 mg/kg). CP 99,994 inhibits aerosolized capsaicin-induced plasma extravasation in guinea pig lung (ID50 = 4 mg/kg). It exhibits anti-emetic effects in ferret models of emesis induced by copper sulfate, loperamide, or cisplatin (Item No. 13119) when administered at doses of 0.3 and 1 mg/kg.{46650}  

     

    Brand:
    Cayman
    SKU:27669 - 10 mg

    Available on backorder

  • CP 99,994 is a nonpeptide neurokinin-1 (NK1) receptor antagonist (Ki = 0.25 nM in a radioligand binding assay).{46649} It is selective for NK1 over NK2 and NK3 receptors (Kis = >10 μM for both) as well as dopamine D1 and D2, α1-, α2- and β-adrenergic, serotonin, histamine H1, muscarinic and nicotinic acetylcholine, μ-opioid, glutamate, benzodiazepine, and γ-aminobutyric acid (GABA) receptors (IC50s = >1 μM for all). In vitro, CP 99,994 inhibits excitation of guinea pig locus coeruleus cells induced by substance P (Item No. 24035; IC50 = 25 nM). It inhibits increases in horizontal locomotor activity induced by the NK1 agonist [Sar9,Met(O2)11]-substance P in guinea pigs (ID50 = 0.59 mg/kg). CP 99,994 inhibits aerosolized capsaicin-induced plasma extravasation in guinea pig lung (ID50 = 4 mg/kg). It exhibits anti-emetic effects in ferret models of emesis induced by copper sulfate, loperamide, or cisplatin (Item No. 13119) when administered at doses of 0.3 and 1 mg/kg.{46650}  

     

    Brand:
    Cayman
    SKU:27669 - 5 mg

    Available on backorder

  • CP-392,110 is an AMPA receptor antagonist.{53055} It inhibits AMPA receptor-mediated calcium uptake in rat cerebellar neurons (IC50 = 74 nM). CP-392,110 inhibits seizures induced by pentylenetetrazol (Item No. 18682) or AMPA (Item No. 14571) in mice with ID50 values of 3.8 and 3.6 mg/kg, respectively.  

     

    Brand:
    Cayman
    SKU:20473 -

    Available on backorder

  • CP-392,110 is an AMPA receptor antagonist.{53055} It inhibits AMPA receptor-mediated calcium uptake in rat cerebellar neurons (IC50 = 74 nM). CP-392,110 inhibits seizures induced by pentylenetetrazol (Item No. 18682) or AMPA (Item No. 14571) in mice with ID50 values of 3.8 and 3.6 mg/kg, respectively.  

     

    Brand:
    Cayman
    SKU:20473 -

    Available on backorder

  • CP-392,110 is an AMPA receptor antagonist.{53055} It inhibits AMPA receptor-mediated calcium uptake in rat cerebellar neurons (IC50 = 74 nM). CP-392,110 inhibits seizures induced by pentylenetetrazol (Item No. 18682) or AMPA (Item No. 14571) in mice with ID50 values of 3.8 and 3.6 mg/kg, respectively.  

     

    Brand:
    Cayman
    SKU:20473 -

    Available on backorder

  • CP21R7 is a potent and selective inhibitor of GSK3β.{32916} It is used as an activator of stem cells prior to the induction of differentiation of stem cells to endothelial and smooth muscle cells.{32915,32917,32918} GSK3β inhibitors, including CP21R7, can be used with BMP4 to commit human pluripotent stem cells to a mesodermal fate.{32917,32918}  

     

    Brand:
    Cayman
    SKU:20573 -

    Available on backorder

  • CP21R7 is a potent and selective inhibitor of GSK3β.{32916} It is used as an activator of stem cells prior to the induction of differentiation of stem cells to endothelial and smooth muscle cells.{32915,32917,32918} GSK3β inhibitors, including CP21R7, can be used with BMP4 to commit human pluripotent stem cells to a mesodermal fate.{32917,32918}  

     

    Brand:
    Cayman
    SKU:20573 -

    Available on backorder

  • CP21R7 is a potent and selective inhibitor of GSK3β.{32916} It is used as an activator of stem cells prior to the induction of differentiation of stem cells to endothelial and smooth muscle cells.{32915,32917,32918} GSK3β inhibitors, including CP21R7, can be used with BMP4 to commit human pluripotent stem cells to a mesodermal fate.{32917,32918}  

     

    Brand:
    Cayman
    SKU:20573 -

    Available on backorder

  • CP21R7 is a potent and selective inhibitor of GSK3β.{32916} It is used as an activator of stem cells prior to the induction of differentiation of stem cells to endothelial and smooth muscle cells.{32915,32917,32918} GSK3β inhibitors, including CP21R7, can be used with BMP4 to commit human pluripotent stem cells to a mesodermal fate.{32917,32918}  

     

    Brand:
    Cayman
    SKU:20573 -

    Available on backorder

  • CPCCOEt is a low affinity, selective, non-competitive antagonist of the metabotropic glutamate receptor subtype mGluR1b. It has been shown to inhibit glutamate-induced increases in intracellular calcium at human mGluR1b with an IC50 value of 6.5 µM while having no agonist or antagonist activity at mGluR2, -4a, -5a, -7b, and -8a at concentrations up to 100 µM.{33623}  

     

    Brand:
    Cayman
    SKU:21486 -

    Out of stock

  • CPCCOEt is a low affinity, selective, non-competitive antagonist of the metabotropic glutamate receptor subtype mGluR1b. It has been shown to inhibit glutamate-induced increases in intracellular calcium at human mGluR1b with an IC50 value of 6.5 µM while having no agonist or antagonist activity at mGluR2, -4a, -5a, -7b, and -8a at concentrations up to 100 µM.{33623}  

     

    Brand:
    Cayman
    SKU:21486 -

    Out of stock

  • CPCCOEt is a low affinity, selective, non-competitive antagonist of the metabotropic glutamate receptor subtype mGluR1b. It has been shown to inhibit glutamate-induced increases in intracellular calcium at human mGluR1b with an IC50 value of 6.5 µM while having no agonist or antagonist activity at mGluR2, -4a, -5a, -7b, and -8a at concentrations up to 100 µM.{33623}  

     

    Brand:
    Cayman
    SKU:21486 -

    Out of stock

  • CpdA is a non-steroidal selective glucocorticoid receptor modulator.{33998} It is an aziridine precursor that can infiltrate cells and is translocated to the nucleus.{33998,33996} It inhibits glucocorticoid receptor dimerization, which prevents transcription of gene targets such as NF-κB and subsequent cytokines through transrepression.{33997} Studies have shown contradictory results for binding affinity of CpdA compared with dexamethasone (Item No. 11015) that were either higher (4-fold, IC50 = 6.4 nM and 25.9 nM, respectively, in L929sA cells) or lower (63-fold, Kd = 81.8 nM and 1.29 nM, respectively, in BWTG3 cells) in whole cell binding assays.{33996,33997}  

     

    Brand:
    Cayman
    SKU:21438 -

    Out of stock

  • CpdA is a non-steroidal selective glucocorticoid receptor modulator.{33998} It is an aziridine precursor that can infiltrate cells and is translocated to the nucleus.{33998,33996} It inhibits glucocorticoid receptor dimerization, which prevents transcription of gene targets such as NF-κB and subsequent cytokines through transrepression.{33997} Studies have shown contradictory results for binding affinity of CpdA compared with dexamethasone (Item No. 11015) that were either higher (4-fold, IC50 = 6.4 nM and 25.9 nM, respectively, in L929sA cells) or lower (63-fold, Kd = 81.8 nM and 1.29 nM, respectively, in BWTG3 cells) in whole cell binding assays.{33996,33997}  

     

    Brand:
    Cayman
    SKU:21438 -

    Out of stock

  • CpdA is a non-steroidal selective glucocorticoid receptor modulator.{33998} It is an aziridine precursor that can infiltrate cells and is translocated to the nucleus.{33998,33996} It inhibits glucocorticoid receptor dimerization, which prevents transcription of gene targets such as NF-κB and subsequent cytokines through transrepression.{33997} Studies have shown contradictory results for binding affinity of CpdA compared with dexamethasone (Item No. 11015) that were either higher (4-fold, IC50 = 6.4 nM and 25.9 nM, respectively, in L929sA cells) or lower (63-fold, Kd = 81.8 nM and 1.29 nM, respectively, in BWTG3 cells) in whole cell binding assays.{33996,33997}  

     

    Brand:
    Cayman
    SKU:21438 -

    Out of stock

  • CpdA is a non-steroidal selective glucocorticoid receptor modulator.{33998} It is an aziridine precursor that can infiltrate cells and is translocated to the nucleus.{33998,33996} It inhibits glucocorticoid receptor dimerization, which prevents transcription of gene targets such as NF-κB and subsequent cytokines through transrepression.{33997} Studies have shown contradictory results for binding affinity of CpdA compared with dexamethasone (Item No. 11015) that were either higher (4-fold, IC50 = 6.4 nM and 25.9 nM, respectively, in L929sA cells) or lower (63-fold, Kd = 81.8 nM and 1.29 nM, respectively, in BWTG3 cells) in whole cell binding assays.{33996,33997}  

     

    Brand:
    Cayman
    SKU:21438 -

    Out of stock

  • Serum amyloid P (SAP) is pentraxin with roles in inflammation and immune response.{30496,30495} CPHPC is a divalent crosslinker of SAP that causes rapid depletion of circulating SAP via hepatic clearance.{10002} It also produces significant reduction of SAP from cerebrospinal fluid and visceral amyloid deposits.{10002,30497,18818} CPHPC has been used with anti-SAP antibodies to eliminate amyloid deposits in clinical trials of systemic amyloidosis.{18818,30498}  

     

    Brand:
    Cayman
    SKU:75500 - 10 mg

    Available on backorder

  • Serum amyloid P (SAP) is pentraxin with roles in inflammation and immune response.{30496,30495} CPHPC is a divalent crosslinker of SAP that causes rapid depletion of circulating SAP via hepatic clearance.{10002} It also produces significant reduction of SAP from cerebrospinal fluid and visceral amyloid deposits.{10002,30497,18818} CPHPC has been used with anti-SAP antibodies to eliminate amyloid deposits in clinical trials of systemic amyloidosis.{18818,30498}  

     

    Brand:
    Cayman
    SKU:75500 - 5 mg

    Available on backorder

  • Serum amyloid P (SAP) is pentraxin with roles in inflammation and immune response.{30496,30495} CPHPC is a divalent crosslinker of SAP that causes rapid depletion of circulating SAP via hepatic clearance.{10002} It also produces significant reduction of SAP from cerebrospinal fluid and visceral amyloid deposits.{10002,30497,18818} CPHPC has been used with anti-SAP antibodies to eliminate amyloid deposits in clinical trials of systemic amyloidosis.{18818,30498}  

     

    Brand:
    Cayman
    SKU:75500 - 50 mg

    Available on backorder

  • CPI-1189 is a benzamide with neuroprotective and anti-inflammatory activities.{45675,45676,45677,45678,45679} It inhibits phosphorylation of p38 MAPK in IL-1β-stimulated primary rat astrocytes by 70 to 80% when used at concentrations ranging from 10 to 300 nM.{45675} CPI-1189 (20 mg/kg per day) reduces TNF-α-induced apoptosis in the corpus callosum and septum, but not in the neocortex or basal ganglia, as well as reduces TNF-α-induced decreases in GFAP levels in isolated rat brain slices.{45676} It decreases the latency to find the platform in the Morris water maze, indicating reversal of memory deficits, induced by TNF-α in a rat model of AIDS dementia when administered at a dose of 20 mg/kg per day.{45677} CPI-1189 (30 mg/kg per day) reduces crypt loss and decreases the number of ulcers and inflammatory cells in colonic lesions in mouse models of colitis induced by TNBS or dextran sulfate sodium (DSS; Item No. 23250).{45678,45679}  

     

    Brand:
    Cayman
    SKU:29187 - 100 mg

    Available on backorder

  • CPI-1189 is a benzamide with neuroprotective and anti-inflammatory activities.{45675,45676,45677,45678,45679} It inhibits phosphorylation of p38 MAPK in IL-1β-stimulated primary rat astrocytes by 70 to 80% when used at concentrations ranging from 10 to 300 nM.{45675} CPI-1189 (20 mg/kg per day) reduces TNF-α-induced apoptosis in the corpus callosum and septum, but not in the neocortex or basal ganglia, as well as reduces TNF-α-induced decreases in GFAP levels in isolated rat brain slices.{45676} It decreases the latency to find the platform in the Morris water maze, indicating reversal of memory deficits, induced by TNF-α in a rat model of AIDS dementia when administered at a dose of 20 mg/kg per day.{45677} CPI-1189 (30 mg/kg per day) reduces crypt loss and decreases the number of ulcers and inflammatory cells in colonic lesions in mouse models of colitis induced by TNBS or dextran sulfate sodium (DSS; Item No. 23250).{45678,45679}  

     

    Brand:
    Cayman
    SKU:29187 - 25 mg

    Available on backorder

  • CPI-1189 is a benzamide with neuroprotective and anti-inflammatory activities.{45675,45676,45677,45678,45679} It inhibits phosphorylation of p38 MAPK in IL-1β-stimulated primary rat astrocytes by 70 to 80% when used at concentrations ranging from 10 to 300 nM.{45675} CPI-1189 (20 mg/kg per day) reduces TNF-α-induced apoptosis in the corpus callosum and septum, but not in the neocortex or basal ganglia, as well as reduces TNF-α-induced decreases in GFAP levels in isolated rat brain slices.{45676} It decreases the latency to find the platform in the Morris water maze, indicating reversal of memory deficits, induced by TNF-α in a rat model of AIDS dementia when administered at a dose of 20 mg/kg per day.{45677} CPI-1189 (30 mg/kg per day) reduces crypt loss and decreases the number of ulcers and inflammatory cells in colonic lesions in mouse models of colitis induced by TNBS or dextran sulfate sodium (DSS; Item No. 23250).{45678,45679}  

     

    Brand:
    Cayman
    SKU:29187 - 250 mg

    Available on backorder

  • CPI-1189 is a benzamide with neuroprotective and anti-inflammatory activities.{45675,45676,45677,45678,45679} It inhibits phosphorylation of p38 MAPK in IL-1β-stimulated primary rat astrocytes by 70 to 80% when used at concentrations ranging from 10 to 300 nM.{45675} CPI-1189 (20 mg/kg per day) reduces TNF-α-induced apoptosis in the corpus callosum and septum, but not in the neocortex or basal ganglia, as well as reduces TNF-α-induced decreases in GFAP levels in isolated rat brain slices.{45676} It decreases the latency to find the platform in the Morris water maze, indicating reversal of memory deficits, induced by TNF-α in a rat model of AIDS dementia when administered at a dose of 20 mg/kg per day.{45677} CPI-1189 (30 mg/kg per day) reduces crypt loss and decreases the number of ulcers and inflammatory cells in colonic lesions in mouse models of colitis induced by TNBS or dextran sulfate sodium (DSS; Item No. 23250).{45678,45679}  

     

    Brand:
    Cayman
    SKU:29187 - 50 mg

    Available on backorder

  • The lysine methyltransferase EZH2 (KMT6), part of the polycomb repressive complex 2, catalyzes trimethylation of lysine 27 on histone H3 (H3K27me3) and is involved in proliferation and aggressive cell growth associated with neoplastic cells. CPI-169 is a selective EZH2 inhibitor with IC50 values of 0.24, 0.51, and 6.1 nM for wild-type EZH2, Y641N mutant EZH2, and wild-type EZH1, respectively.{29633} It decreases cellular levels of H3K27me3 (EC50 = 70 nM), triggering cell cycle arrest and ultimately resulting in apoptosis in a large panel of non-Hodgkin’s lymphoma (NHL) cell lines.{29633} With subcutaneous administration of 200 mg/kg/twice a day, CPI-169 was shown to inhibit tumor growth in a NHL xenograft model, reducing global H3K27me3.{29633} It has also been shown to synergize with the B-cell lymphoma 2 inhibitor, ABT-199 (Item No. 16233), to suppress the growth of NHL cell lines.{29633}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • The lysine methyltransferase EZH2 (KMT6), part of the polycomb repressive complex 2, catalyzes trimethylation of lysine 27 on histone H3 (H3K27me3) and is involved in proliferation and aggressive cell growth associated with neoplastic cells. CPI-169 is a selective EZH2 inhibitor with IC50 values of 0.24, 0.51, and 6.1 nM for wild-type EZH2, Y641N mutant EZH2, and wild-type EZH1, respectively.{29633} It decreases cellular levels of H3K27me3 (EC50 = 70 nM), triggering cell cycle arrest and ultimately resulting in apoptosis in a large panel of non-Hodgkin’s lymphoma (NHL) cell lines.{29633} With subcutaneous administration of 200 mg/kg/twice a day, CPI-169 was shown to inhibit tumor growth in a NHL xenograft model, reducing global H3K27me3.{29633} It has also been shown to synergize with the B-cell lymphoma 2 inhibitor, ABT-199 (Item No. 16233), to suppress the growth of NHL cell lines.{29633}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder